Definitive Healthcare (NASDAQ:DH) Posts Earnings Results, Meets Expectations

Definitive Healthcare (NASDAQ:DH) issued its quarterly earnings data on Monday. The company reported $0.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.09, Briefing.com reports. Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. The company had revenue of $63.70 million for the quarter, compared to the consensus estimate of $63.19 million. During the same quarter last year, the business posted $0.08 earnings per share. The firm’s revenue was up 4.4% compared to the same quarter last year. Definitive Healthcare updated its Q3 guidance to $0.07-0.08 EPS.

Definitive Healthcare Stock Up 4.9 %

Shares of DH stock traded up $0.18 during midday trading on Wednesday, reaching $3.83. 2,617,498 shares of the stock were exchanged, compared to its average volume of 824,852. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $11.44. The company’s 50 day moving average is $5.37 and its two-hundred day moving average is $6.96. The company has a current ratio of 2.30, a quick ratio of 2.30 and a debt-to-equity ratio of 0.20. The firm has a market cap of $451.69 million, a PE ratio of -2.19, a price-to-earnings-growth ratio of 4.58 and a beta of 1.30.

Analysts Set New Price Targets

Several brokerages have issued reports on DH. JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and dropped their price target for the stock from $7.00 to $5.00 in a research note on Wednesday, July 31st. Stifel Nicolaus dropped their price target on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research note on Wednesday, July 31st. Robert W. Baird dropped their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday. William Blair reissued an “outperform” rating on shares of Definitive Healthcare in a research note on Tuesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating for the company in a research note on Thursday, May 9th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Definitive Healthcare has an average rating of “Hold” and an average target price of $7.75.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.